This supplement contains the following items:
|
|
- Harry Wiggins
- 5 years ago
- Views:
Transcription
1 This supplement contains the following items: 1. Original protocol, final protocol, summary of changes 2. Original statistical analysis plan, final statistical analysis plan, summary of changes Original protocol VERTOS IV trial ClinicalTrials.gov Identifier: NCT Purpose The standard care in patients with a painful osteoporotic vertebral compression fracture (VCF) is conservative therapy. Percutaneous vertebroplasty (PV), is a new minimally invasive technique for pain treatment in which bone cement is injected in the fractured vertebra. Recent RCTs provide conflicting results: two sham-controlled studies show no benefit of PV while an unmasked but controlled RCT found significantly better pain relief after PV at acceptable costs. Study Type: Study Design: Interventional Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment Objectives To evaluate the efficacy of bone cement injection in PV for patients with acute painful osteoporotic compression fractures, as compared with a simulated placebo procedure without injection of bone cement. We hypothesize that patients who had undergone PV would report less pain at 1 day, 1 week and 1, 3, 6 and 12 months (the primary outcomes) than those in the sham control group. Study design VERTOS IV is a multicenter RCT concerning the treatment of patients with a painful osteoporotic VCF. Patients are recruited on the Radiology departments of the participating hospitals and randomized to PV or a simulated procedure. Upon obtaining informed consent an independent central telephone operator completes the randomization procedure, using a computer program. The maximum allowed unbalance (block size) is six, with a maximum sample size of 84 for each participating center. A total of 180 patients will be enrolled, 90 in each group. This is based on the assumption of a 1.5 point difference in pain relief (VAS Score) and a 20% withdrawal rate (α=0.05 and β=0.20, 7 measurement points). The enrolment of patients will take place in four centres in The Netherlands: St. Elisabeth Ziekenhuis in Tilburg, Catharina Ziekenhuis in Eindhoven, Medisch Spectrum Twente in Enschede and Albert Schweitzer Ziekenhuis in Dordrecht. Randomization will start January 2011 with an expected completion of enrolment by January There is a one-year follow-up, with the possibility of an extended follow-up at two years. The overall Institutional Review Board is approval is obtained at the St. Elisabeth Hospital in Tilburg. In addition, each participating center will obtain a local Institutional Review Board Approval. This study is registered at ClinicalTrials.gov., NCT Osteoporosis- and pain medication. All patients receive osteoporosis medication, such as bisphosphonates together with supplemental calcium and vitamin D. Pain medication demanded by the patient is recorded. Analgesics are classified following the WHO classification: (1) Paracetamol (acetaminophen), (2) Tramadol, (3) Tramadol and Paracetamol, (4) Morphine. Non Steroid Anti Inflammatory Drugs (NSAID) are only
2 prescribed if patients are intolerant for opiate- derivatives or when already used. Corrections in dose and classification of pain medication are made if necessary. Clinical follow-up An experienced nurse-practitioner requests patients to fill out a standard questionnaire before and at 1 day, 1 week, and 1, 3, 6 and 12 months after the procedure. The questionnaire consist of the VAS score and questions about use of pain medication, pain location, and pain type. The VAS score is a pain score ranging from 0 (no pain) to 10 (worst pain ever. Other medical treatment and visits to alternative medical specialists, GP's and physical therapists are recorded and compared between groups. Secondary outcomes are back pain related disability and QOL as measured with the Roland Morris Disability (RMD) Questionnaire and the Questionnaire of the European Foundation for Osteoporosis (Qualeffo), respectively. The Qualeffo is developed specifically for patients with osteoporosis. This questionnaire consists of 41 questions about: pain, physical function, social function, general health perception, and mental function. The Qualeffo score ranges from 0 (best quality of life) to 100 (worst quality of life). This questionnaire will be completed at five measurement moments (before and at 1, 3, 6, and 12 months after the procedure). The RMD questionnaire is a disability questionnaire that measures the functional status of patients with back pain. The RMD will be completed at all measurement points. All patients visit the internist at 1,3,6 and 12 months follow-up. All patients receive a pain diary. Patients are asked to fill out the VAS score and use of analgesics is recorded on a daily basis during the first month after randomization. Sample size considerations Assuming a 1.5 point difference in pain relief as measured by VAS score and a withdrawal rate of 20% (α=0.05 and β=0.20, 7 measurement points), a total of 180 patients will be enrolled, 90 in each group. Criteria Inclusion Criteria: VCF on X-ray of the spine (minimal 15% loss of height) level of VCF Th5 or lower back pain 6 weeks at time of X-ray 50 years of age bone edema on MRI of the fractured vertebral body focal tenderness on VCF level decreased bone density T-scores -1 Exclusion Criteria: severe cardio-pulmonary condition untreatable coagulopathy systemic or local infection of the spine (osteomyelitis, spondylodiscitis) suspected alternative underlying disease (malignancy) radicular and/or cauda compression syndrome contra-indication for MRI Randomization Arms
3 Experimental: vertebroplasty Using fluoroscopic guidance, the practitioner infiltrates the skin and subcutaneous tissues overlying the pedicle of the target vertebra or vertebrae with 1% lidocaine and infiltrates the periosteum of the pedicles with 0.25% bupivacaine (marcaine). For the vertebroplasty procedure, 11-gauge or 13-gauge needles are passed into the central aspect of the target vertebra or vertebrae. Bone cement is prepared on the bench and injected under constant fluoroscopy into the vertebral body. Injection is stopped when the cement reaches to the posterior aspect of the vertebral body or leaks into an extraosseous space, such as the intervertebral disk or an epidural or paravertebral vein. Sham Comparator: sham procedure Using fluoroscopic guidance, the practitioner infiltrates the skin and subcutaneous tissues overlying the pedicle of the target vertebra or vertebrae with 1% lidocaine and infiltrates the periosteum of the pedicles with 0.25% bupivacaine (marcaine). During the sham intervention, verbal and physical cues, such as pressure on the patient's back, are given, and the bone cement is prepared to simulate the odor associated with mixing of polymethacrylate, but the needle is not placed and cement is not injected. Primary outcome measures: pain relief [ Time Frame: 12 months ] Primary outcome will be pain relief at 1 day, 1 week, and 1,3, 6 and 12 months. The questionnaire consist of the VAS score and questions about use of pain medication, pain location, and pain type. Other medical treatment and visits to alternative medical specialists, GP's and physical therapists are recorded and compared between groups. Patients are asked to fill out the VAS score and use of analgesics is recorded on a daily basis during the first month after randomization. Secondary Outcome Measures back pain related disability [ Time Frame: 0, 1day, 1 week, 1,3,6,12 months ] Back pain related disability as measured with the Roland Morris Disability (RMD) Questionnaire. The Qualeffo is developed specifically for patients with osteoporosis. This questionnaire consists of 41 questions about: pain, physical function, social function, general health perception, and mental function. The RMD questionnaire is a disability questionnaire that measures the functional status of patients with back pain! Quality of Life [ Time Frame: 1 week, 1,3,6,12 months ]! QOL as measured with the Questionnaire of the European Foundation for Osteoporosis (Qualeffo). The Qualeffo is developed specifically for patients with osteoporosis. This questionnaire consists of 41 questions about: pain, physical function, social function, general health perception, and mental function. The Qualeffo score ranges from 0 (best quality of life) to 100 (worst quality of life). This questionnaire will be completed at five measurement moments (before and at 1, 3, 6, and 12 months after the procedure). Final protocol VERTOS IV trial ClinicalTrials.gov Identifier: NCT
4 Purpose The standard care in patients with a painful osteoporotic vertebral compression fracture (VCF) is conservative therapy. Percutaneous vertebroplasty (PV), is a new minimally invasive technique for pain treatment in which bone cement is injected in the fractured vertebra. Recent RCTs provide conflicting results: two sham-controlled studies show no benefit of PV while an unmasked but controlled RCT found significantly better pain relief after PV at acceptable costs. Study Type: Study Design: Interventional Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment Objectives To evaluate the efficacy of bone cement injection in PV for patients with acute painful osteoporotic compression fractures, as compared with a simulated placebo procedure without injection of bone cement. We hypothesize that patients who had undergone PV would report less pain at 1 day, 1 week and 1, 3, 6 and 12 months (the primary outcomes) than those in the sham control group. Study design VERTOS IV is a multicenter RCT concerning the treatment of patients with a painful osteoporotic VCF. Patients are recruited on the Radiology departments of the participating hospitals and randomized to PV or a simulated procedure. Upon obtaining informed consent an independent central telephone operator completes the randomization procedure, using a computer program. The maximum allowed unbalance (block size) is six, with a maximum sample size of 84 for each participating center. A total of 180 patients will be enrolled, 90 in each group. This is based on the assumption of a 1.5 point difference in pain relief (VAS Score) and a 20% withdrawal rate (α=0.05 and β=0.20, 7 measurement points). The enrolment of patients will take place in four centres in The Netherlands: St. Elisabeth Ziekenhuis in Tilburg, Catharina Ziekenhuis in Eindhoven, Medisch Spectrum Twente in Enschede and Albert Schweitzer Ziekenhuis in Dordrecht. Randomization will start January 2011 with an expected completion of enrolment by January There is a one-year follow-up, with the possibility of an extended follow-up at two years. The overall Institutional Review Board is approval is obtained at the St. Elisabeth Hospital in Tilburg. In addition, each participating center will obtain a local Institutional Review Board Approval. This study is registered at ClinicalTrials.gov., NCT Osteoporosis- and pain medication All patients receive osteoporosis medication, such as bisphosphonates together with supplemental calcium and vitamin D. Pain medication demanded by the patient is recorded. Analgesics are classified following the WHO classification: (1) Paracetamol (acetaminophen), (2) Tramadol, (3) Tramadol and Paracetamol, (4) Morphine. Non Steroid Anti Inflammatory Drugs (NSAID) are only prescribed if patients are intolerant for opiate- derivatives or when already used. Corrections in dose and classification of pain medication are made if necessary. Clinical follow-up An experienced nurse-practitioner requests patients to fill out a standard questionnaire before and at 1 day, 1 week, and 1, 3, 6 and 12 months after the procedure. The questionnaire consist of the VAS score and questions about use of pain medication, pain location, and pain type. The VAS score is a pain score ranging from 0 (no pain) to 10
5 (worst pain ever. Other medical treatment and visits to alternative medical specialists, GP's and physical therapists are recorded and compared between groups. Secondary outcomes are back pain related disability and QOL as measured with the Roland Morris Disability (RMD) Questionnaire and the Questionnaire of the European Foundation for Osteoporosis (Qualeffo), respectively. The Qualeffo is developed specifically for patients with osteoporosis. This questionnaire consists of 41 questions about: pain, physical function, social function, general health perception, and mental function. The Qualeffo score ranges from 0 (best quality of life) to 100 (worst quality of life). This questionnaire will be completed at five measurement moments (before and at 1, 3, 6, and 12 months after the procedure). The RMD questionnaire is a disability questionnaire that measures the functional status of patients with back pain. The RMD will be completed at all measurement points. All patients visit the internist at 1,3,6 and 12 months follow-up. All patients receive a pain diary. Patients are asked to fill out the VAS score and use of analgesics is recorded on a daily basis during the first month after randomization. Sample size considerations Assuming a 1.5 point difference in pain relief as measured by VAS score and a withdrawal rate of 20% (α=0.05 and β=0.20, 7 measurement points), a total of 180 patients will be enrolled, 90 in each group. Criteria Inclusion Criteria: VCF on X-ray of the spine (minimal 15% loss of height) level of VCF Th5 or lower back pain 6 weeks at time of X-ray, extended up to maximum of 9 weeks 50 years of age bone edema on MRI of the fractured vertebral body focal tenderness on VCF level decreased bone density T-scores -1 Exclusion Criteria: severe cardio-pulmonary condition untreatable coagulopathy systemic or local infection of the spine (osteomyelitis, spondylodiscitis) suspected alternative underlying disease (malignancy) radicular and/or cauda compression syndrome contra-indication for MRI Randomization Arms Experimental: vertebroplasty Using fluoroscopic guidance, the practitioner infiltrates the skin and subcutaneous tissues overlying the pedicle of the target vertebra or vertebrae with 1% lidocaine and infiltrates the periosteum of the pedicles with 0.25% bupivacaine (marcaine). For the vertebroplasty
6 procedure, 11-gauge or 13-gauge needles are passed into the central aspect of the target vertebra or vertebrae. Bone cement is prepared on the bench and injected under constant fluoroscopy into the vertebral body. Injection is stopped when the cement reaches to the posterior aspect of the vertebral body or leaks into an extraosseous space, such as the intervertebral disk or an epidural or paravertebral vein. Sham Comparator: sham procedure Using fluoroscopic guidance, the practitioner infiltrates the skin and subcutaneous tissues overlying the pedicle of the target vertebra or vertebrae with 1% lidocaine and infiltrates the periosteum of the pedicles with 0.25% bupivacaine (marcaine). During the sham intervention, verbal and physical cues, such as pressure on the patient's back, are given, and the bone cement is prepared to simulate the odor associated with mixing of polymethacrylate, but the needle is not placed and cement is not injected. Primary outcome measures: pain relief [ Time Frame: 12 months ] Primary outcome will be pain relief at 1 day, 1 week, and 1,3, 6 and 12 months. The questionnaire consist of the VAS score and questions about use of pain medication, pain location, and pain type. Other medical treatment and visits to alternative medical specialists, GP's and physical therapists are recorded and compared between groups. Patients are asked to fill out the VAS score and use of analgesics is recorded on a daily basis during the first month after randomization. Secondary Outcome Measures back pain related disability [ Time Frame: 0, 1day, 1 week, 1,3,6,12 months ]! Back pain related disability as measured with the Roland Morris Disability (RMD) Questionnaire. The Qualeffo is developed specifically for patients with osteoporosis. This questionnaire consists of 41 questions about: pain, physical function, social function, general health perception, and mental function. The RMD questionnaire is a disability questionnaire that measures the functional status of patients with back pain Quality of Life [ Time Frame: 1 week, 1,3,6,12 months ]! QOL as measured with the Questionnaire of the European Foundation for Osteoporosis (Qualeffo). The Qualeffo is developed specifically for patients with osteoporosis. This questionnaire consists of 41 questions about: pain, physical function, social function, general health perception, and mental function. The Qualeffo score ranges from 0 (best quality of life) to 100 (worst quality of life). This questionnaire will be completed at five measurement moments (before and at 1, 3, 6, and 12 months after the procedure). Summary of all amendments: One inclusion criteria was modified during the study due to a scarce inclusion: Back pain 6 weeks at time of X-ray was extended up to 9 weeks Original Statistical analysis The data will be analyzed according to the intention-to-treat principle. Standard statistical techniques will be used to describe characteristics of patients in both groups. We will compare baseline characteristics in the two treatment groups and if incomparability appears, we will in secondary analysis adjust for differences. The primary outcome, significant pain relief will be compared with the analysis of variance for repeated measures. If adjustment for possible baseline incomparability is needed, analysis of covariance will be done. Since we
7 expect the difference between the two groups will particularly become evident at 3, 6 and 12 months, the analysis will also be performed at these time points. Final Statistical analysis Analyses were performed using IBM SPSS statistics 23 and the R programming software (R development Core Team, 2008)16. P-values< 0.05 were considered to indicate statistical significance. G-Power was used to calculate the sample size. Based on Klazen et al.7, assuming a 2 point VAS difference, a pooled standard deviation of 4.23 and 20% withdrawal (α= 0.05 and β= 0.20 at 7 time points), 90 patients needed to be included in each group. Analysis was by intention to treat, meaning that we have analysed our patients based on their initial treatment assignment. Proportions of adverse events, drugs, and baseline fractures were compared using 2 tests. In Table 1 (baseline characteristics), for continuous and normally distributed variables, means and standard deviation were computed whereas for non-normally distributed variables the median and interquartile range were reported. Our primary endpoint (difference between groups in mean reduction of VAS during 12 months follow-up) and secondary endpoints (difference between groups in mean reduction of QUALEFFO & RMDQ during 12 months follow-up) were analysed using a mixed modelling approach. The statistical interaction between treatment and time was used to evaluate the primary and secondary endpoints. Tests for differences between the groups at specific time points were derived directly from the mixed model by making use of the custom hypothesis test command in the SPSS syntax. A mixed model analysis makes use of all available data for each participant, thereby accounting for data missing at random. Model estimates were adjusted based on the covariates age, gender, vertebral level, pain treatment, osteonecrosis, new fractures after baseline and progressive vertebral height loss. A first-order autoregressive covariance structure was used to model the repeated measurements. The extent to which patients reached significant pain relief over time was analysed with Cox regression analysis. Differences between the survival curves of the two groups were assessed using the log-rank test. Following the analysis of our primary objective, exploratory post-hoc analyses were done to determine whether progressive vertebral height loss interacted with treatment in predicting the pain intensity during one-year follow-up. Chi-square tests were used to assess the difference between groups in the occurrence of new fractures and to examine the difference in proportion of patients in each group with a VAS score of 5 or higher at 12 months follow-up. Generalized mixed modelling was used to investigate differences between groups in the use of pain medication during 12 month follow-up. Summary of all amendments: No intention-to-treat principle was applicable as there were no cross- over cases. One inclusion criteria was modified during the study due to a scarce inclusion: Back pain 6 weeks at time of X-ray was extended up to 9 weeks. Following the analysis of our primary objective, exploratory post-hoc analyses were done to determine whether progressive vertebral height loss interacted with treatment in predicting the pain intensity during one-year follow-up. Chi-square tests were used to assess the difference between groups in the occurrence of new fractures and to examine the difference in proportion of patients in each group with a VAS score of 5 or higher at 12 months
8 follow-up. Generalized mixed modelling was used to investigate differences between groups in the use of pain medication during 12 month follow-up.
Percutaneous vertebroplasty (PV) consists of the percutaneous
ORIGINAL RESEARCH M.H.J. Voormolen W.P.T.M. Mali P.N.M. Lohle H. Fransen L.E.H. Lampmann Y. van der Graaf J.R. Juttmann X. Jansssens H.J.J. Verhaar Percutaneous Vertebroplasty Compared with Optimal Pain
More information24-Febr Dear members of the BMJ Editorial team,
24-Febr-2018 Manuscript ID BMJ.2017.042734 entitled "A randomised sham controlled clinical trial of vertebroplasty for painful acute osteoporotic vertebral compression fractures (VERTOS IV)" Dear members
More informationFracture REduction Evaluation (FREE) Study
Fracture REduction Evaluation (FREE) Study Efficacy and Safety of Balloon Kyphoplasty Compared with Non-surgical Care for Vertebral Compression Fracture (FREE): A Randomised Controlled Trial Wardlaw Lancet
More informationVertebral Augmentation for Compression Fractures. Scott Magnuson, MD Pain Management of North Idaho, PLLC
Vertebral Augmentation for Compression Fractures Scott Magnuson, MD Pain Management of North Idaho, PLLC OVCFs are most common type of fragility fracture 20-25% Caucasian women and men over 50 yrs have
More informationRESEARCH. the bmj BMJ 2018;361:k1551 doi: /bmj.k1551 1
Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial Cristina E Firanescu, 1 Jolanda de Vries, 1,2
More informationGeneral introduction and outlines of this thesis
General introduction and outlines of this thesis 1 Background Since its introduction in 1984 percutaneous vertebroplasty (PV) has been progressively performed with success in mainly France and from the
More informationPercutaneous Vertebroplasty for Treatment of Painful Osteoporotic Vertebral Compression Fractures
Ontario Health Technology Assessment Series 2010; Vol. 10, No. 19 Percutaneous Vertebroplasty for Treatment of Painful Osteoporotic Vertebral Compression Fractures An Evidence-Based Analysis Presented
More informationPercutaneous Vertebroplasty and Sacroplasty
Percutaneous Vertebroplasty and Sacroplasty Policy Number: 6.01.25 Last Review: 11/2017 Origination: 2/2001 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide
More informationThe role of imaging procedures before percutaneous vertebroplasty
ORIGINAL RESEARCH M.H.J. Voormolen W.J. van Rooij M. Sluzewski Y. van der Graaf L.E.H. Lampmann P.N.M. Lohle J.R. Juttmann Pain Response in the First Trimester after Percutaneous Vertebroplasty in Patients
More informationOutline Vertebroplasty and Kyphoplasty: Who, What, and When
Outline Vertebroplasty and Kyphoplasty: Who, What, and When Douglas C. Bauer, MD University of California San Francisco, USA Vertebral fracture epidemiology, consequences and diagnosis Kyphoplasty and
More informationVertebral augmentation: report of the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery
For numbered affiliations see end of article. Correspondence to Dr Mahesh V Jayaraman, Warren Alpert School of Medical at Brown University, Providence, RI 2903, USA; MJayaraman@Lifespan.org Received 16
More informationB3D-MC-GHCY Clinical Study Report Synopsis Page 1Page GHCY Synopsis LY
B3DMCGHCY Clinical Study Report Page 1Page 1 2. GHCY B3DMCGHCY Clinical ClinicalStudy StudyReport Report Page 2Page 2 Clinical Study Report : Study B3DMCGHCY Title of Study: The Effect of Teriparatide
More informationVertebral Body Augmentation
Vertebral Body Augmentation Nitin Sekhri MD Department of Anesthesiology Department of Radiology Westchester Medical Center Maria Fareri Children's Hospital Assistant Professor of Anesthesiology New York
More informationPERCUTANEOUS VERTEBROPLASTY AND KYPHOPLASTY
Oxford UnitedHealthcare Oxford Clinical Policy PERCUTANEOUS VERTEBROPLASTY AND KYPHOPLASTY Policy Number: PAIN 023.3 T2 Effective Date: October 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Percutaneous Vertebroplasty and Sacroplasty Page 1 of 21 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Percutaneous Vertebroplasty and Sacroplasty Professional
More informationPercutaneous Vertebroplasty and Sacroplasty
Percutaneous Vertebroplasty and Sacroplasty Policy Number: 6.01.25 Last Review: 11/2018 Origination: 2/2001 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide
More informationOutline. Vertebroplasty and Kyphoplasty. Epidemiology. Identifying Vertebral Fractures. Page 1
Outline Vertebroplasty and Kyphoplasty Douglas C. Bauer, MD University of California San Francisco, USA Vertebral fracture epidemiology, consequences and diagnosis Kyphoplasty and vertebroplasty: what
More informationClinialTrials.gov Identifier: Sponsor/company: sanofi-aventis
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationOutline Vertebroplasty and Kyphoplasty: Who, What, and When
Outline Vertebroplasty and Kyphoplasty: Who, What, and When Douglas C. Bauer, MD University of California San Francisco, USA Vertebral fracture epidemiology, consequences and diagnosis Kyphoplasty and
More informationName of Policy: Percutaneous Vertebroplasty, Kyphoplasty, Mechanical Vertebral Augmentation and Sacroplasty
Name of Policy: Percutaneous Vertebroplasty, Kyphoplasty, Mechanical Vertebral Augmentation and Sacroplasty Policy #: 004 Latest Review Date: July 2014 Category: Radiology/Surgical Policy Grade: B Background/Definitions:
More informationService: Imaging. Vertebroplasty. Exceptional healthcare, personally delivered
Service: Imaging Exceptional healthcare, personally delivered Your Doctor has requested that you have a vertebroplasty. We hope the following information will answer some of the questions you may have
More informationPercutaneous Vertebroplasty for Acute Osteoporotic Vertebral Fracture Contributes to Restoration of Ambulation
Original Research Percutaneous Vertebroplasty for Acute Osteoporotic Vertebral Fracture Contributes to Restoration of Ambulation 1) Department of Radiology, National Center for Global Health and Medicine,
More informationPain Management Clinic ISIC
Pain Management Clinic ISIC Let us rebuild a pain free life Pain is one of the commonest symptoms in patients attending OPDs of various hospitals and clinics. Chronic pain is any pain that has persisted
More informationTilburg University. Document version: Publisher's PDF, also known as Version of record. Publication date: Link to publication
Tilburg University Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II) Klazen, C.A.; Lohle, P.N.; de Vries, Jolanda; Jansen, F.H.; Tielbeek, A.V.;
More informationUse of percutaneous vertebroplasty is increasing as a treatment
ORIGINAL RESEARCH T.J. Kaufmann A.T. Trout D.F. Kallmes The Effects of Cement Volume on Clinical Outcomes of Percutaneous Vertebroplasty BACKGROUND AND PURPOSE: There exists significant variability in
More information14,000 patients received vertebroplasties in 2015
The placebo effect The problem 67 year old male witnessed fall from bicycle X-rays show new compression fractures in thoracic spine and lumbar spine Significant pain and disability 14,000 patients received
More informationRetrospective Evaluation. Pain Physician 2012; 15: ISSN Bassem Georgy, MD
Pain Physician 2012; 15:223-228 ISSN 1533-3159 Retrospective Evaluation Feasibility, Safety and Cement Leakage in Vertebroplasty of Osteoporotic and Malignant Compression Fractures Using Ultra-Viscous
More informationGuide to Percutaneous
Guide to Percutaneous Ve r t e b r o p l a s t y Synergie Ingénierie Médicale S.A.R.L. Z.A. de L Angle - 19370 Chamberet - France rd@synimed.com Guide to Percutaneous Vertebroplasty Notice This guide is
More informationPercutaneous Vertebroplasty-Induced Adjacent Vertebral Compression Fracture. Ki Seong Eom, MD, PhD, and Tae Young Kim, MD, PhD
Pain Physician 2012; 15:E527-E532 ISSN 2150-1149 Case Report Percutaneous Vertebroplasty-Induced Adjacent Vertebral Compression Fracture Ki Seong Eom, MD, PhD, and Tae Young Kim, MD, PhD From: Department
More informationProduct: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1
Date: 21 November 2016 Page 1 2. SYNOPSIS Name of Sponsor: Amgen Inc., Thousand Oaks, CA, USA Name of Finished Product: Prolia Name of Active Ingredient: denosumab Title of Study: Randomized, Double-blind,
More informationINDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER. Volume: Page:
SYNOPSIS Protocol No: OROS-ANA-3001 Title of Study: Randomized, open-label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared
More informationClinical Data and Efficacy in the Treatment of Vertebral Compression Fractures. Author Affiliation
Clinical Data and Efficacy in the Treatment of Vertebral Compression Fractures Author Affiliation 1 Perception vs. Reality Perception Patients get better by themselves with bed rest Vertebroplasty doesn
More informationCAN WE PREDICT SURGERY FOR SCIATICA?
7 CAN WE PREDICT SURGERY FOR SCIATICA? Improving prediction of inevitable surgery during non-surgical treatment of sciatica. Wilco C. Peul Ronald Brand Raph T.W.M. Thomeer Bart W. Koes Submitted for publication
More informationISPUB.COM. Percutaneous Vertebroplasty In Osteoporotic Compression Fractures. R Chahal, S Acharya
ISPUB.COM The Internet Journal of Spine Surgery Volume 3 Number 1 Percutaneous Vertebroplasty In Osteoporotic Compression Fractures R Chahal, S Acharya Citation R Chahal, S Acharya.. The Internet Journal
More informationManagement of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital
Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Common problems in myeloma Myeloma-related complications/symptoms
More informationEvidence Table. Study Type: Randomized controlled trial. Study Aim: To evaluate the safety and efficacy of the X-Stop interspinous implant.
Evidence Table Clinical Area: Reference: Spinal decompression device for lumbar spinal stenosis Zucherman JF et al. A prospective randomized multi-center study for the treatment of lumbar spinal stenosis
More informationKyphoplasty and Vertebroplasty
Kyphoplasty and Vertebroplasty Policy Number: Original Effective Date: MM.06.007 01/11/2005 Line(s) of Business: Current Effective Date: HMO; PPO 02/01/2012 Section: Surgery Place(s) of Service: Inpatient;
More informationDiscussion Points 10/17/16. Spine Pain is Ubiquitous. Interventional Pain Management
Interventional Pain Management Blake Christensen, D.O. Fellowship Trained Interventional Pain Management Board Eligible in Anesthesiology and Interventional Pain Management Oklahoma Interventional Pain
More informationYOUR SUDDEN BACK PAIN MAY BE A FRACTURE
YOUR SUDDEN BACK PAIN MAY BE A FRACTURE Sudden-onset back pain could signal a spinal fracture. TALK WITH YOUR DOCTOR If you have tried treatments like rest and oral medication for more than a few days
More informationControl. Control Through VISCOSITY Control Through DELIVERY Control Through SIMPLICITY
Control. Now that s CONFIDENCE. Control Through VISCOSITY Control Through DELIVERY Control Through SIMPLICITY Control throughviscosity Controlled Fill Cement Interdigitation Low viscosity cement Trabecular
More informationPERCUTANEOUS BALLOON KYPHOPLASTY, RADIOFREQUENCY KYPHOPLASTY, AND MECHANICAL VERTEBRAL AUGMENTATION
KYPHOPLASTY, AND MECHANICAL VERTEBRAL AUGMENTATION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,
More informationBackground and Significance To be completed by the project s Principal Investigator (PI) and should include rationale for the selected study design.
Study Design: Randomized placebo controlled trial of third occipital nerve radiofrequency neurotomy applied according to guidelines established by the International Spine Intervention Society. Background
More informationEvidence based Practice Changes Spinal Injections
Evidence based Practice Changes Spinal Injections Kathryn Mueller, MD, MPH, FACOEM Professor, School of Public Health & Department of Physiatry - University of Colorado President - American College of
More informationPercutaneous Vertebroplasty, Kyphoplasty, and Sacroplasty
Medical Coverage Policy Effective Date... 9/15/2018 Next Review Date... 5/15/2019 Coverage Policy Number... 0040 Percutaneous Vertebroplasty, Kyphoplasty, and Sacroplasty Table of Contents Coverage Policy...
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Multiple Technology Appraisal (MTA)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Multiple Technology Appraisal (MTA) Percutaneous Vertebroplasty (PVP) and Balloon Kyphoplasty (BKP) for the treatment of Osteoporotic Vertebral Compression
More informationArticles. Funding Education grant from CareFusion Corporation.
Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial William Clark, Paul Bird, Peter Gonski, Terrence
More informationDRAFT as posted for public comment 11/8/2016 to 8 a.m. 12/9/2016. HERC Coverage Guidance
HEALTH EVIDENCE REVIEW COMMISSION (HERC) COVERAGE GUIDANCE: LOW BACK PAIN - CORTICOSTEROID INJECTIONS HERC Coverage Guidance Corticosteroid injections (including epidural, facet joint, medial branch, and
More informationProDisc-C versus fusion with Cervios chronos prosthesis in cervical degenerative disc disease: Is there a difference at 12 months?
Original research ProDisc-C versus fusion with Cervios chronos prosthesis in cervical degenerative disc ( ) 51 51 56 ProDisc-C versus fusion with Cervios chronos prosthesis in cervical degenerative disc
More informationUTERINE FIBROID EMBOLIZATION
INTERVENTIONAL RADIOLOGY PROTOCOLS UTERINE FIBROID EMBOLIZATION Interventional Radiology Tower Health Medical Group offers the option to treat uterine fibroids with fibroid embolization (UFE), an alternative
More informationPrevious Study Return to List Next Study
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: 42603ATT3013 Previous Study Return to List Next Study A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS
More informationPercutaneous vertebroplasty is a relatively noninvasive,
ORIGINAL RESEARCH F. Al-Ali T. Barrow K. Luke Vertebroplasty: What Is Important and What Is Not BACKGROUND AND PURPOSE: It is important to try to clarify the methodology of vertebroplasty such as amount
More informationPercutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty
Medical Policy Manual Surgery, Policy No. 107 Percutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty Next Review: April 2019 Last Review: April 2018 Effective: June 1, 2018 IMPORTANT
More informationIndications for Kyphoplasty and Vertebroplasty
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationCHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials
CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule
More informationKYPHON Balloon Kyphoplasty
KYPHON Results from a randomized controlled study comparing KYPHON to nonsurgical care for treatment of vertebral compression fractures Relief. Mobility. Quality of Life. What is? KYPHON is a minimally
More informationInterventional Pain Management
Spinal Injections Can be beneficial for both chronic and acute pain depending on pathology Contraindications: Patient refusal Active infection Platelets less than 75 or inability to stop anticoagulation
More informationBalloon kyphoplasty is now considered as minimally invasive
Published February 7, 2013 as 10.3174/ajnr.A3424 ORIGINAL RESEARCH SPINE In Not Only Vertebroplasty but Also Kyphoplasty, the Resolution of Vertebral Deformities Depends on Vertebral Mobility K. Yokoyama,
More informationManagement of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust
Management of complications and side-effects of myeloma Jackie Quinn Myeloma CNS Belfast Trust Common problems in myeloma Myeloma-related complications/symptoms Treatment-related side-effects Myeloma bone
More informationComparison of Vertebroplasty Versus Vertebral Perforation for the Treatment of Acute Vertebral Compression Fractures
DOI: 10.5137/1019-5149.JTN.12158-14.4 Received: 23.07.2014 / Accepted: 13.05.2015 Published Online: 16.02.2016 Original Investigation Comparison of Vertebroplasty Versus Vertebral Perforation for the Treatment
More informationInter-hospital Geriatric Meeting: An older lady with low back pain: Is the new technology useful? Presenter: Dr Ma HM Supervisor: Dr Ho WS PWH
Inter-hospital Geriatric Meeting: An older lady with low back pain: Is the new technology useful? Presenter: Dr Ma HM Supervisor: Dr Ho WS PWH Case History [1] 87/F, Madam Tsang Admitted to the medical
More informationVertebroplasty has been widely and successfully used in the
ORIGINAL RESEARCH E.M. Knavel K.R. Thielen D.F. Kallmes Vertebroplasty for the Treatment of Traumatic Nonosteoporotic Compression Fractures BACKGROUND AND PURPOSE: Vertebroplasty is commonly used for osteoporotic
More informationPercutaneous vertebroplasty appears to be an effective minimally
ORIGINAL RESEARCH L.A. Gray A. Ehteshami Rad J.R. Gaughen, Jr. T.J. Kaufmann D.F. Kallmes Efficacy of Percutaneous Vertebroplasty for Multiple Synchronous and Metachronous Vertebral Compression Fractures
More informationOriginal Article Risk factors of new symptomatic vertebral compression fractures after percutaneous vertebroplasty
Int J Clin Exp Med 2019;12(1):949-954 www.ijcem.com /ISSN:1940-5901/IJCEM0076385 Original Article Risk factors of new symptomatic vertebral compression fractures after percutaneous vertebroplasty Zhen
More informationStudy Design: Prospective observational study of cervical interlaminar injection of steroid in patients with cervical radicular pain
Study Design: Prospective observational study of cervical interlaminar injection of steroid in patients with cervical radicular pain Background and Significance To be completed by the project s Principal
More informationCLINICAL GUIDELINES. Primary Care Guideline Summary Lumbar Spine Thomas J. Gilbert M.D., M.P.P. 3/17/15 revision
CLINICAL GUIDELINES Primary Care Guideline Summary Lumbar Spine Thomas J. Gilbert M.D., M.P.P. 3/17/15 revision TRIAGE At the initial visit, a focused history and physical examination is performed to assign
More informationPercutaneous Vertebroplasty: Indications, Technique, and Results Sequence of Operations
Percutaneous Vertebroplasty: Indications, Technique, and Results Sequence of Operations Technique: Sequence of Operations Materials Dual Guidance Local Anesthesia Puncture Vertebral Body Biopsy Vertebral
More informationTranslating Evidence into Practice
Translating Evidence into Practice Professor John R Zalcberg Head of Cancer Research Program School of Public Health and Preventive Medicine USA TRIAL Why do trials here? DEFINE TRIAL ANALYSED ABSTRACT
More informationVertebroplasty has been widely accepted as an effective
Published June 26, 2008 as 10.3174/ajnr.A1186 ORIGINAL RESEARCH A.E. Rad D.F. Kallmes Pain Relief Following Vertebroplasty in Patients with and without Localizing Tenderness on Palpation BACKGROUND AND
More informationVertebral compression model and comparison of augmentation agents
23 23 27 Vertebral compression model and comparison of augmentation agents Authors Clint Hill, Scott Wingerter, Doug Parsell, Robert McGuire Institution Department of Orthopedic Surgery and Rehabilitation,
More informationVertebral puncture reduces vertebral fracture-associated pain-do osteoplastic procedures qualify as successful placebo interventions?
Vertebral puncture reduces vertebral fracture-associated pain-do osteoplastic procedures qualify as successful placebo interventions? Objective: The results of three randomized sham-controlled trials investigating
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Facet Joint Denervation Page 1 of 20 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Facet Joint Denervation Professional Institutional Original Effective Date:
More informationRipamonti C, et al. ASCO 2012 (Abstract 9005)
ZOOM: A Prospective, Randomized Trial of Zoledronic Acid for Long-term Treatment in Patients With Bone-Metastatic Breast Cancer After 1 Year of Standard Zoledronic Acid Treatment D. Amadori, M. Aglietta,
More informationManaging Bone Pain in Metastatic Disease. Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018
Managing Bone Pain in Metastatic Disease Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018 None Disclosures Managing Bone Pain in Metastatic Disease This lecture will
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional overview of percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture
More informationRadiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management
Session 5: Symptoms management Radiotherapy symptoms control in bone mets Francesco Cellini GemelliART Ernesto Maranzano,MD Director of Oncology Department Chief of Radiation Oncology Centre S. Maria Hospital
More informationSpine Pain Management Program
Spine Pain Management Program Please complete the following information: Patient Name: Patient ID Number: Patient DOB: The procedure being requested: Epidural Adhesiolysis Please check the indication (reason)
More informationSponsor / Company: sanofi-aventis and Proctor & Gamble Drug substance(s): Risedronate (HMR4003)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: sanofi-aventis and
More informationEfficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: CZOL446H2409 Previous Study Return to List Next Study Efficacy Study of Zoledronic Acid and Combination Therapy in Women With
More informationStudy Design: Prospective observational study of cervical transforaminal epidural steroid injections in patients with cervical radicular pain
Study Design: Prospective observational study of cervical transforaminal epidural steroid injections in patients with cervical radicular pain Background and Significance To be completed by the project
More informationCT-guided percutaneous pedicle screw fixation followed by cementoplasty in the treatment of metastatic spinal disease
CT-guided percutaneous pedicle screw fixation followed by cementoplasty in the treatment of metastatic spinal disease Claudio Pusceddu Dpt of Interventional Radiology Oncological Hospital AOBrotzu Cagliari
More informationRadiologic Finding of Failed Percutaneous Vertebroplasty
Radiologic Finding of Failed Percutaneous Vertebroplasty Liu, Wei Chiang 1, M.D., Sang-Ho Lee 2, M.D., Won Gyu Choi 2, M.D., Dong-Yeob Lee 2, M.D., Sung Suk Paeng 3, M.D., Amy Kwon 4, Ph.D. Department
More informationA Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures
Journals A-Z New England Journal of Medicine 361(6) August 2009 A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures. The New England Journal of Medicine Issue: Volume 361(6),
More informationVertebroplasty: why and how to perform it?
Vertebroplasty: why and how to perform it? Poster No.: C-2289 Congress: ECR 2014 Type: Educational Exhibit Authors: H. Derbel, I. Naccache, A. Beyram, A. Neffati, R. Bennaceur, 1 2 2 2 1 1 1 2 2 H. Rajhi,
More informationVERTEBRAL CEMENT AUGMENTATION PROCEDURES: COMPARISION BETWEEN KYPHOPLASTY AND VERTEBROPLASTY
VERTEBRAL CEMENT AUGMENTATION PROCEDURES: COMPARISION BETWEEN KYPHOPLASTY AND VERTEBROPLASTY Dr. Majesh Pratap Malla* and Dr. She Yuan Ju Department of Orthopaedics, Clinical Medical College of Yangtze
More informationManaging Skeletal Metastases
School of Breast Oncology 2012 Managing Skeletal Metastases Cathy Van Poznak, MD Assistant Professor University of Michigan Comprehensive Cancer Center Saturday, November 3, 2012 Learning Objectives: Define
More informationPercutaneous Vertebroplasty and Sacroplasty. Description
Subject: Percutaneous Vertebroplasty and Sac roplasty Page: 1 of 17 Last Review Status/Date: June 2015 Percutaneous Vertebroplasty and Sacroplasty Description Percutaneous vertebroplasty is an interventional
More informationAalborg Universitet. Statistical analysis plan Riis, Allan; Karran, E. L. ; Jørgensen, Anette; Holst, S.; Rolving, N. Publication date: 2017
Aalborg Universitet Statistical analysis plan Riis, Allan; Karran, E. L. ; Jørgensen, Anette; Holst, S.; Rolving, N. Publication date: 2017 Document Version Publisher's PDF, also known as Version of record
More informationSpine Pain Management Program
Spine Pain Management Program Please complete the following information: Patient Name: Patient ID Number: Patient DOB: The procedure being requested: Facet Injection Please check the indication (reason)
More informationBack Pain Update. Steven Andersen, MD Providence Physiatry Clinic 2016
Back Pain Update Steven Andersen, MD Providence Physiatry Clinic 2016 Back Pain is Very Common Lifetime prevalence 80% 12 month prevalence 40% Point prevalence 20% Centers for Disease Control and Prevention.
More informationAvailable from Deakin Research Online: Reproduced with the kind permission of the copyright owner.
Deakin Research Online Deakin University s institutional research repository DDeakin Research Online Research Online This is the published version (version of record) of: Buchbinder, Rachelle, Osborne,
More informationPain Management. University of Illinois at Chicago College of Nursing
Pain Management University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this module, participants will be better able to: 1. Define pain management 2. Explore various
More informationSpine Pain Management Program
Spine Pain Management Program Please complete the following information: Patient Name: Patient ID Number: Patient DOB: The procedure being requested: Epidural Injection Please check the indication (reason)
More informationPercutaneous Vertebroplasty
12 Percutaneous Vertebroplasty John M. Mathis and Charles Cho Introduction Vertebroplasty is a term that describes a surgical therapy that has been performed as an open operative procedure for decades,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Friedly JL, Comstock BA, Turner JA, et al. A randomized trial
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Facet Joint Denervation Page 1 of 22 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Facet Joint Denervation Professional Institutional Original Effective Date:
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous coblation of the intervertebral disc for low back pain and sciatica
More informationQiang Wang, Hong-Guang Xu, Li-Jun Dong, Hong Wang, Jin-Song Zhu
Int J Clin Exp Med 2016;9(2):4095-4100 www.ijcem.com /ISSN:1940-5901/IJCEM0017186 Original Article Comparison of hyperextension reduction and balloon dilation method combined with vertebroplasty in treatment
More informationInstruction for use of Kyphoplasty Balloon Catheter
Instruction for use of Kyphoplasty Balloon Catheter Instruction for the use of Kyphoplasty Balloon Catheter Product name Kyphoplasty Balloon Catheter Structure Figure 1 Peanut type 1-Radiopaque maker,
More informationCost utility analysis of balloon kyphoplasty and vertebroplasty in the treatment of vertebral compression fractures in the United States
The University of Toledo The University of Toledo Digital Repository Theses and Dissertations 2013 Cost utility analysis of balloon kyphoplasty and vertebroplasty in the treatment of vertebral compression
More information